MRTX

Mirati Therapeutics, Inc. Common Stock
MRTX

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

MRTX was delisted on the 22nd of January, 2024.

Back to rankings
 

About: Mirati Therapeutics Inc is a clinical-stage oncology company developing novel therapeutics to address the genetic and immunological promoters of cancer. It operates in a single geographical segment being the United States.

Employees: 593

Healthcare Drug Manufacturers - General
Price charts implemented using Lightweight Charts™